Comprehensive testing for breast cancer evaluating DNA and RNA
September 23, 2019
Genomic Testing cooperative (GTC) provides a comprehensive genomic profiling of breast cancer including evaluating: – Actional mutations– Gene amplification and deletion– Hormonal expression levels– Microsatellite stability (MSI)– Tumor mutation burden (TMB)– Homologous recombination deficiency (HRD) status and homologous recombination repair (HRR) gene testing The GTC tests for breast cancer (Liquid